Literature DB >> 12841630

Oral administration of orthovanadate and Trigonella foenum graecum seed power restore the activities of mitochondrial enzymes in tissues of alloxan-induced diabetic rats.

Shalini Thakran1, Najma Z Baquer.   

Abstract

The effect of oral administration of sodium orthovanadate (SOV) and Trigonella foenum graecum seed powder (TSP), a medicinal plant used extensively in Asia, on the mitochondrial metabolism in the alloxan diabetic rats has been investigated. Rats were injected with alloxan monohydrate (20 mg/100 g body wt) or vehicle (Na-acetate buffer), the former were treated with either 2 IU insulin i.p., 0.6 mg/ml SOV ad libitum, 5% TSP ad libitum, and a combination of 0.2% SOV and 5% TSP ad libitum for 21 days. Selected rate-limiting enzymes of the tricarboxylic acid cycle, hydrogen shuttle system, ketone body metabolism, amino acid metabolism and urea cycle were measured in the mitochondrial and cytosolic fractions of liver, kidney and brain tissues of the experimental rats. Majority of the mitochondrial enzymes in the tissues of the diabetic rats had significantly higher activities compared to the control rats. Similarly, the activities of mitochondrial and cytosolic aminotransferases and arginase were significantly higher in liver and kidney tissues of the diabetic rats. The separate administrations of SOV and TSP to diabetic rats were able to restore the activities of these enzymes to control values. The lower dose of SOV (0.2%) administered in combination with TSP to diabetic rats lowered the enzyme activities more significantly than when given in a higher dose (0.6%) separately. This is the first report of the effective combined action of oral SOV and TSP in ameliorating the altered mitochondrial enzyme activities during experimental type-1 diabetes. Our novel combined oral administration of SOV and TSP to diabetic rats thus conclusively proves as a possible method to minimize potential vanadate toxicity without compromising its positive effects in the therapy of experimental type-1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12841630     DOI: 10.1023/a:1024188600523

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  36 in total

Review 1.  Mitochondrial DNA in aging and degenerative disease.

Authors:  C D Berdanier; H B Everts
Journal:  Mutat Res       Date:  2001-04-18       Impact factor: 2.433

2.  Improving effects obtained by the ovariectomy or treatment with tamoxifen of female diabetic rats over the function and enzyme activities of liver mitochondria.

Authors:  J A Brignone; C M de Brignone; I R de Mignone; C R Ricci; M C Susemihl; R R Rodríguez
Journal:  Horm Metab Res       Date:  1991-02       Impact factor: 2.936

Review 3.  Mitochondrial diseases in man and mouse.

Authors:  D C Wallace
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

4.  Effects of vanadate and insulin on the activities of selected enzymes of amino acid metabolism in alloxan diabetic rat kidney.

Authors:  K C Upadhyaya; N Z Baquer
Journal:  Biochem Mol Biol Int       Date:  1996-11

5.  Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.

Authors:  A J Barber; E Lieth; S A Khin; D A Antonetti; A G Buchanan; T W Gardner
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

6.  Effect of Trigonella foenum graecum (Fenugreek) on blood glucose in normal and diabetic rats.

Authors:  P Khosla; D D Gupta; R K Nagpal
Journal:  Indian J Physiol Pharmacol       Date:  1995-04

7.  Effects of thyroid hormone deficiency on the distribution of hepatic metabolites and control of pathways of carbohydrate metabolism in liver and adipose tissue of the rat.

Authors:  N Z Baquer; M Cascales; P McLean; A L Greenbaum
Journal:  Eur J Biochem       Date:  1976-09-15

8.  Impaired antioxidant status in diabetic rat liver. Effect of vanadate.

Authors:  A K Saxena; P Srivastava; R K Kale; N Z Baquer
Journal:  Biochem Pharmacol       Date:  1993-02-09       Impact factor: 5.858

Review 9.  Drug metabolism and toxicity during hypoxia.

Authors:  D P Jones; T Y Aw; X Q Shan
Journal:  Drug Metab Rev       Date:  1989       Impact factor: 4.518

10.  Alterations in antioxidant enzymes and oxidative damage in experimental diabetic rat tissues: effect of vanadate and fenugreek (Trigonellafoenum graecum).

Authors:  Solomon Genet; Raosaheb K Kale; Najma Z Baquer
Journal:  Mol Cell Biochem       Date:  2002-07       Impact factor: 3.396

View more
  5 in total

Review 1.  Metabolic and molecular action of Trigonella foenum-graecum (fenugreek) and trace metals in experimental diabetic tissues.

Authors:  Najma Zaheer Baquer; Pardeep Kumar; Asia Taha; R K Kale; S M Cowsik; P McLean
Journal:  J Biosci       Date:  2011-06       Impact factor: 1.826

2.  Long-term effect of Trigonella foenum graecum and its combination with sodium orthovanadate in preventing histopathological and biochemical abnormalities in diabetic rat ocular tissues.

Authors:  Anju Preet; M R Siddiqui; A Taha; J Badhai; M E Hussain; P K Yadava; N Z Baquer
Journal:  Mol Cell Biochem       Date:  2006-05-23       Impact factor: 3.396

3.  Trigonella foenum graecum seed powder protects against histopathological abnormalities in tissues of diabetic rats.

Authors:  Shalini Thakran; M R Siddiqui; Najma Z Baquer
Journal:  Mol Cell Biochem       Date:  2004-11       Impact factor: 3.396

4.  Elicitation of Diosgenin Production in Trigonella foenum-graecum (Fenugreek) Seedlings by Methyl Jasmonate.

Authors:  Spandan Chaudhary; Surendra K Chikara; Mahesh C Sharma; Abhinav Chaudhary; Bakhtiyar Alam Syed; Pooja S Chaudhary; Aditya Mehta; Maulik Patel; Arpita Ghosh; Marcello Iriti
Journal:  Int J Mol Sci       Date:  2015-12-15       Impact factor: 5.923

5.  Diabetes, a Contemporary Risk for Parkinson's Disease: Epidemiological and Cellular Evidences.

Authors:  Domenico Sergi; Justine Renaud; Nicola Simola; Maria-Grazia Martinoli
Journal:  Front Aging Neurosci       Date:  2019-11-08       Impact factor: 5.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.